Authors
Richard Conway, Alyssa A Grimshaw, Maximilian F Konig, Michael Putman, Alí Duarte‐García, Leslie Yingzhijie Tseng, Diego M Cabrera, Yu Pei Eugenia Chock, Huseyin Berk Degirmenci, Eimear Duff, Bugra Han Egeli, Elizabeth R Graef, Akash Gupta, Patricia Harkins, Bimba F Hoyer, Arundathi Jayatilleke, Shangyi Jin, Christopher Kasia, Aneka Khilnani, Adam Kilian, Alfred HJ Kim, Chung Mun Alice Lin, Candice Low, Laurie Proulx, Sebastian E Sattui, Namrata Singh, Jeffrey A Sparks, Herman Tam, Manuel F Ugarte‐Gil, Natasha Ung, Kaicheng Wang, Leanna M Wise, Ziyi Yang, Kristen J Young, Jean W Liew, Rebecca Grainger, Zachary S Wallace, Evelyn Hsieh, COVID‐19 Global Rheumatology Alliance
Publication date
2022/5
Source
Arthritis & Rheumatology
Volume
74
Issue
5
Pages
766-775
Publisher
Wiley Periodicals, Inc.
Description
Objective
The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among people with rheumatic and musculoskeletal diseases (RMDs) compared to those without RMDs is unclear. This study was undertaken to quantify the risk of SARS–CoV‐2 infection in those with RMDs and describe clinical outcomes of COVID‐19 in these patients.
Methods
We conducted a systematic literature review using 14 databases from January 1, 2019 to February 13, 2021. We included observational studies and experimental trials in RMD patients that described comparative rates of SARS–CoV‐2 infection, hospitalization, oxygen supplementation/intensive care unit (ICU) admission/mechanical ventilation, or death attributed to COVID‐19. Methodologic quality was evaluated using the Joanna Briggs Institute critical appraisal tools or the Newcastle‐Ottawa scale. Risk ratios (RRs) and odds ratios (ORs) with 95 …
Total citations
Scholar articles
R Conway, AA Grimshaw, MF Konig, M Putman… - Arthritis & Rheumatology, 2022
R Conway, A Grimshaw, M Konig, M Putman… - ARTHRITIS & RHEUMATOLOGY, 2021